Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

Nomogram aids clinical decision making after radical cystectomy

Accurate estimates of treatment success, complications and long-term morbidity are essential for patients to make informed medical decisions regarding treatment. Several multivariate prediction models have been developed to predict patient outcome after radical cystectomy (RC) for bladder cancer. The IBCNC postcystectomy nomogram can improve clinical decision making and therefore patient outcome. The inclusion of biomarkers might improve the accuracy of nomogram predictions in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Shariat, S. F., Karakiewicz, P. I., Roehrborn, C. G. & Kattan, M. W. An updated catalog of prostate cancer predictive tools. Cancer 113, 3075–3099 (2008).

    Article  PubMed  Google Scholar 

  2. Shariat, S. F., Margulis, V., Lotan, Y., Montorsi, F. & Karakiewicz, P. I. Nomograms for bladder cancer. Eur. Urol. 54, 41–53 (2008).

    Article  PubMed  Google Scholar 

  3. Karakiewicz, P. I. et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J. Urol. 176, 1354–1361; discussion 1361–1362 (2006).

    Article  PubMed  Google Scholar 

  4. Shariat, S. F. et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin. Cancer Res. 12, 6663–6676 (2006).

    Article  PubMed  Google Scholar 

  5. International Bladder Cancer Nomogram Consortium, Bochner, B. H., Kattan, M. W. & Vora, K. C. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24, 3967–3972 (2006).

    Article  PubMed  Google Scholar 

  6. Vickers, A. J., Cronin, A. M., Elkin, E. B. & Gonen, M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak. 8, 53 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Vickers, A. J. et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 115, 5460–5469 (2009).

    Article  PubMed  Google Scholar 

  8. Shariat, S. F. et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 112, 315–325 (2008).

    Article  PubMed  Google Scholar 

  9. Margulis, V. et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J. Natl Cancer Inst. 101, 114–119 (2009).

    Article  PubMed  Google Scholar 

  10. Karam, J. A. et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol. 8, 128–136 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahrokh F. Shariat.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shariat, S., Tilki, D. Nomogram aids clinical decision making after radical cystectomy. Nat Rev Urol 7, 182–184 (2010). https://doi.org/10.1038/nrurol.2010.42

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2010.42

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer